Can harmonized regulation overcome intra-European differences? Insights from a European Phase III stem cell trial

  • Christine Hauskeller
  • Regenerative Medicine, October 2017, Future Medicine
  • DOI: 10.2217/rme-2017-0064

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2217/rme-2017-0064

The following have contributed to this page: Christine Hauskeller